# X thread draft — The Artificial Paracrine System: Robust Control of Extracellular-Vesicle Signaling Under Biological Uncertainty

1/14 Aging involves multiple interacting processes. One question worth isolating: can a narrow tissue-level signaling objective be regulated despite noisy measurements and uncertain dynamics?

2/14 The Artificial Paracrine System (APS) is a proposed sensing–estimation–control–actuation architecture. It is a research framework, not a demonstrated rejuvenation device.

3/14 EVs carry proteins, lipids, and nucleic acids and are studied in intercellular communication and therapeutic delivery. Their production, cargo loading, targeting, and safety remain substantial challenges.

4/14 Start with a local model, not a universal “youth state”:

$$
\dot{x}=Ax+Bu+Ew,\quad y=Cx+v.
$$

5/14 Here x is a defined tissue state, u a bounded intervention, w disturbances, and v measurement noise. Every state and parameter would need operational definitions and data.

6/14 H-infinity control asks whether disturbance-to-output amplification can be bounded under a specified model and uncertainty set. It does not guarantee stability outside those assumptions.

7/14 A central prerequisite: observability. If available measurements cannot distinguish important states, the controller cannot reliably infer what it needs to correct.

8/14 Another prerequisite: controllability under safety constraints. A mathematically controllable toy system does not imply a biological target is safely controllable.

9/14 Information theory gives useful baselines. For a binary symmetric channel, C = 1 − H₂(p). Biochemical signaling is not generally a binary, memoryless channel, so this is an analogy—not an aging clock.

10/14 Generative molecular design is not validated treatment. Candidate payloads still require synthesis, identity and potency characterization, delivery testing, off-target evaluation, and safety review.

11/14 The supplied verifier tests a synthetic two-state plant, controllability rank, a seeded finite perturbation sweep, and channel-capacity limits. It does not simulate biology.

12/14 Falsification conditions include unobservable state, insufficient actuator authority, destabilizing delays, model uncertainty outside the declared bounds, or effects explained by toxicity and nonspecific stress.

13/14 The contribution is a falsifiable integration framework. Novelty is not claimed as established priority; EV engineering, aging-related EV signaling, microfluidics, and robust control all have prior literature.

14/14 Preprint and reproducibility artifacts: https://github.com/Devanik21/The-Invention-Archive/tree/main/Theoretical%20Research/The_Artificial_Paracrine_System_Robust_Control_of_Extracellular_Vesicle_Signaling_Under_Biological_Uncertainty
Source: paper.tex · Verification: verify_model.py · Draft only; no DOI or external publication claimed.
